Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular...

Barrow Neurological Institute opens major new neuroscience facility PHOENIX, April 19, 2022 (GLOBE NEWSWIRE) -- Barrow Neurological Institute has officially opened a new neuroscience facility that is expected to serve as a national model for enhancing the patient...

Collagen (Gelatin and Collagen Peptide) Market is Expected to Grow at a CAGR of 6.8% to Reach $5.6 Billion by 2025: Meticulous Research® London, March 18, 2020 (GLOBE NEWSWIRE) -- Collagen has a wide range of applications due to its properties such as low viscosity in aqueous solutions, neutral odor, colorlessness, transparency,...

Nutraceutical Ingredients Market Worth $57.5 Billion by 2025-Exclusive Report by Meticulous Research® London, Oct. 16, 2019 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Nutraceutical Ingredients Market by Product Type (Vitamins, Amino Acids, Probiotic, Minerals), Derivation...

Parks Associates to Present Mobile Health Research at the Open Mobile Summit DALLAS, TX--(Marketwired - Nov 11, 2013) - Harry Wang, Director, Health & Mobile Product Research, Parks Associates, is moderating the session "mHealth: Pushing the Needle Forward in...